Zeta Corporation
Zeta Corporation provides the highest quality IVD antibodies for Pathology/IHC. Zeta antibodies are carefully curated to produce reproducible results on formalin-fixed, paraffin-embedded (FFPE) sections manually or using commercially available automated equipment.
Zeta designs and develops tumour-specific biomarkers using cutting-edge technology to uniquely select the immunogens for the RAbMono™ (Rabbit Monoclonal) and MonoMAb™ (Monospecific monoclonal) antibodies. Zeta’s MonoMAb™ and RAbMono™ Antibodies are produced through hybridoma and recombinant technologies.
More from Zeta Corporation:
Zeta utilises its collective knowledge of over 75 years to validate and standardise every antibody individually for immunohistochemistry (IHC). Zeta offers CE-IVD labelled products with European regulatory compliance.
Zeta Corporation's Top Products | ||
|---|---|---|
Product Code | Product Name | Clone |
| Z2001R | AMACR | 13H4 |
| Z2002R | PD-L1 | ZR3 |
| Z2004R | P40 | ZR8 |
| Z2005MRT-R | AMACR + p63 | 13H4 + 4A4 |
| Z2007M | Mammaglobin | 304-1A5 |
| Z2011MR | Mammaglobin Cocktail | 304-1A5+31-A5 |
| Z2016M | p16INK4a | MX007 + JC2 |
| Z2017MRS-R | AMACR+P63+HMW CK | 13H4+4A4+34βE12 |
| Z2023R | PR | ZR4 |
| Z2025R | HER-2/neu (m) | ZR5 |